Fasting + Ketogenic — What the Evidence Says
The controversial frontier
Fasting + ketogenic diets for cancer prevention and treatment is the most hyped AND most cautious area of nutrition oncology. Separating genuine signals from social-media enthusiasm requires slowing down and reading the actual papers.
Longo's fasting-mimicking diet (FMD)
Valter Longo's FMD — 5 consecutive days of ~800 kcal, low-protein, plant-based, done monthly or quarterly — has the most human evidence in cancer. Trials show improved chemotherapy tolerance and possible synergy with treatment. FMD during chemo reduced side effects + may have increased efficacy in multiple small trials.
Ketogenic diet — GBM + select cancers
Strict ketogenic diets (enforced ketosis) are being studied as adjuncts for glioblastoma + some other cancers that depend on glucose metabolism. Results are mixed — some signals of tumour response + improved chemo tolerance, other trials null. NOT recommended as a standalone cancer treatment anywhere credible.
True or False
Fasting can cure cancer.
What about prevention?
For cancer PREVENTION in healthy adults, the most robust fasting evidence is indirect: weight loss → less visceral fat → lower cancer risk. Time-restricted eating (16:8) shows metabolic benefits at 12+ weeks. Direct cancer-prevention evidence from fasting is thinner than the online enthusiasm suggests.
Key Takeaway
Fasting + keto in cancer: real research signals in the treatment-adjunct space (chemo tolerance, rare tumour types), weaker evidence in primary prevention. Never replace standard cancer care with fasting. For prevention in healthy adults, weight management + Mediterranean-ish eating still beats fancy protocols.